Bookbuilding IPO | ₹60 Cr | Listed at BSE SME | Wed, Feb 5, 2025 - Fri, Feb 7, 2025
Amwill Health Care IPO is a book build issue of ₹59.98 crores. The issue is a combination of fresh issue of 0.44 crore shares aggregating to ₹48.88 crores and offer for sale of 0.10 crore shares aggregating to ₹11.10 crores.
Amwill Health Care IPO bidding started from Feb 5, 2025 and ended on Feb 7, 2025. The allotment for Amwill Health Care IPO was finalized on Feb 10, 2025. The shares got listed on BSE SME on Feb 12, 2025.
Amwill Health Care IPO price band is set at ₹111 per share. The lot size for an application is 1,200. The minimum amount of investment required by an retail is ₹1,33,200 (1200 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (2,400 shares), amounting to ₹2,66,400.
Unistone Capital Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Globalworth Securities Ltd..
Refer to Amwill Health Care IPO RHP for detailed Information.
IPO Open
Wed, Feb 5, 2025
IPO Close
Fri, Feb 7, 2025
Issue Price
₹111 per share
Market Cap (Pre-IPO)
₹222.04 Cr
| IPO Date | 5 to 7 Feb, 2025 |
| Listed on | Wed, Feb 12, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹105 to ₹111 |
| Issue Price | ₹111 per share |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 54,03,600 shares (agg. up to ₹60 Cr) |
| Reserved for Market Maker | 2,71,200 shares Globalworth Securities Ltd. (agg. up to ₹3 Cr) |
| Fresh Issue (Ex Market Maker) | 41,32,400 shares (agg. up to ₹46 Cr) |
| Offer for Sale | 10,00,000 shares of ₹10 (agg. up to ₹11 Cr) |
| Net Offered to Public | 51,32,400 shares (agg. up to ₹57 Cr) |
| Share Holding Pre Issue | 1,56,00,000 shares |
| Share Holding Post Issue | 2,00,03,600 shares |
| BSE Script Code | 544353 |
| ISIN | INE0U2L01017 |
Amwill Health Care IPO comprises a total issue size of 54,03,600 shares. The net offer to the public is 51,32,400 shares, after excluding 2,71,200 shares allotted on a firm basis. Of the Net offer 10,26,000 (19.99%) are allocated to QIB, 20,53,200 (40.00%) allocated to NII 20,53,200 (40.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| QIB Shares Offered | 10,26,000 | 19.99% | 18.99% |
| NII (HNI) Shares Offered | 20,53,200 | 40.00% | 38.00% |
| Retail Shares Offered | 20,53,200 | 40.00% | 38.00% |
| Firm Reservations | |||
| Market Maker Shares Offered | 2,71,200 | 5.02% | |
| Total Shares Offered | 54,03,600 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,200 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,33,200 |
| Retail (Max) | 1 | 1,200 | ₹1,33,200 |
| HNI (Min) | 2 | 2,400 | ₹2,66,400 |
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company's manufacturing, packaging, and distribution capabilities.
The product portfolio of the Company is divided into two categories, namely,
The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.
The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.
As of September 30, 2024, the company has 84 employees on payroll.
Competitive Strength
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 28.89 | 18.98 | 12.39 | 6.59 |
| Total Income | 23.25 | 44.28 | 30.28 | 27.62 |
| Profit After Tax | 6.52 | 12.54 | 3.11 | 2.57 |
| NET Worth | 23.68 | 17.16 | 4.60 | 1.49 |
| Reserves and Surplus | 8.08 | 17.11 | 4.57 | 1.46 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of working capital requirements of the Company | 25.00 |
| 2 | Marketing and brand building activities | 5.00 |
| 3 | General corporate purposes | 14.24 |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 73.06% |
| ROCE | 94.16% |
| RoNW | 73.06% |
| PAT Margin | 28.53% |
| Price to Book Value | 10.09 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 8.04 | 6.52 |
| P/E (x) | 13.81 | 17.04 |
| Promoter Holding | 97% | 70.65% |
| Market Cap | ₹222.04 Cr. |
The Amwill Healthcare IPO is subscribed 5.73 times on February 7, 2025 5:04:51 PM (Day 3). The public issue subscribed 4.77 times in the retail category, 7.8 times in the QIB category, and 5.66 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for | Total Application |
|---|---|---|---|---|
| QIB | 7.8 | 10,26,000 | 80,01,600 | 0 |
| NII* | 5.66 | 20,53,200 | 1,16,20,800 | 0 |
| Retail | 4.77 | 20,53,200 | 97,83,600 | 0 |
| Total | 5.73 | 51,32,400 | 2,94,06,000 | 9,413 |
Total Application : 9,413
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Offer relating expenses such as fees to Book Running Lead manager Fixed Fee, Registrar to the Issue, Legal Advisors, Auditors, statutory advertisements and other expenses incurred / to be incurred including promotional expenses. | 0.57 |
| 2 | Underwriting commission, brokerage and selling commission, selling and marketing fees (including Commission/ processing fees for SCSBs, Sponsor Bank, Members of the Syndicate, Registered Brokers, RTAs and CDPs) | 4.75 |
| 3 | Listing fees, Stock Exchange processing/ listing fees, software fees, Depositories’ fees, other regulatory expenses and sundry expenses. | 0.37 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹111.00 |
| Open | ₹88.85 |
| Low | ₹84.45 |
| High | ₹93.25 |
| Last Trade | ₹93.25 |
Lead Manager Reports
Amwill Health Care IPO is a SME IPO of 54,03,600 equity shares of the face value of ₹10 aggregating up to ₹60 Crores. The issue is priced at ₹111 per share. The minimum order quantity is 1200.
The IPO opens on Wed, Feb 5, 2025, and closes on Fri, Feb 7, 2025.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Amwill Health Care IPO using UPI as a payment gateway. Zerodha customers can apply in Amwill Health Care IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Amwill Health Care IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Amwill Health Care IPO opens on Wed, Feb 5, 2025 and closes on Fri, Feb 7, 2025.
Amwill Health Care IPO lot size is 1200, and the minimum amount required for application is ₹1,33,200.
You can apply in Amwill Health Care IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Amwill Health Care IPO will be done on Monday, February 10, 2025, and the allotted shares will be credited to your demat account by Tue, Feb 11, 2025. Check the Amwill Health Care IPO allotment status.
The Amwill Health Care IPO listing date is on Wed, Feb 12, 2025.
